BR112023019820A2 - Suspensão contendo derivado de heterociclidenoacetamida - Google Patents
Suspensão contendo derivado de heterociclidenoacetamidaInfo
- Publication number
- BR112023019820A2 BR112023019820A2 BR112023019820A BR112023019820A BR112023019820A2 BR 112023019820 A2 BR112023019820 A2 BR 112023019820A2 BR 112023019820 A BR112023019820 A BR 112023019820A BR 112023019820 A BR112023019820 A BR 112023019820A BR 112023019820 A2 BR112023019820 A2 BR 112023019820A2
- Authority
- BR
- Brazil
- Prior art keywords
- derivative
- suspension containing
- heterocyclideneacetamide
- present
- heterocyclidenoacetamide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021057713 | 2021-03-30 | ||
| PCT/JP2022/015691 WO2022210784A1 (ja) | 2021-03-30 | 2022-03-29 | ヘテロシクリデンアセトアミド誘導体含有懸濁液 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023019820A2 true BR112023019820A2 (pt) | 2023-11-07 |
Family
ID=83459508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023019820A BR112023019820A2 (pt) | 2021-03-30 | 2022-03-29 | Suspensão contendo derivado de heterociclidenoacetamida |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12564553B2 (https=) |
| EP (1) | EP4316485A4 (https=) |
| JP (3) | JP7175431B1 (https=) |
| KR (1) | KR20230163502A (https=) |
| CN (1) | CN117120048A (https=) |
| AU (1) | AU2022250028A1 (https=) |
| BR (1) | BR112023019820A2 (https=) |
| CA (1) | CA3215750A1 (https=) |
| MX (1) | MX2023011649A (https=) |
| WO (1) | WO2022210784A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3262434A1 (en) | 2022-07-20 | 2025-06-12 | Asahi Kasei Kabushiki Kaisha | Hyaluronic acid derivative drug composition and drug composition |
| WO2025206172A1 (ja) * | 2024-03-28 | 2025-10-02 | 千寿製薬株式会社 | 電子線滅菌処理したヘテロシクリデンアセトアミド誘導体含有組成物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61164725A (ja) | 1985-01-11 | 1986-07-25 | Inoue Japax Res Inc | ワイヤ電極案内 |
| JPH07304663A (ja) * | 1994-03-18 | 1995-11-21 | Senju Pharmaceut Co Ltd | 眼圧降下用点眼剤 |
| EP0686393B1 (en) | 1994-03-18 | 1998-05-20 | Senju Pharmaceutical Co., Ltd. | Ophthalmic preparations containing sarpogrelate for reducing intraocular pressure |
| JP3402195B2 (ja) * | 1997-05-14 | 2003-04-28 | 千寿製薬株式会社 | 再分散性の良い水性懸濁液剤 |
| WO1998051281A1 (en) | 1997-05-14 | 1998-11-19 | Senju Pharmaceutical Co., Ltd. | Aqueous suspension preparations with excellent redispersibility |
| NZ565080A (en) | 2005-07-22 | 2011-03-31 | Mochida Pharm Co Ltd | Novel heterocyclidene acetamide derivative |
| WO2008123396A1 (ja) * | 2007-03-29 | 2008-10-16 | Santen Pharmaceutical Co., Ltd. | フルオロメトロンを含有する懸濁型点眼剤 |
| ES2493641T3 (es) * | 2007-06-28 | 2014-09-12 | Cydex Pharmaceuticals, Inc. | Administración nasal de soluciones acuosas de corticosteroides |
| JP6230743B1 (ja) * | 2017-05-31 | 2017-11-15 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の結晶 |
| WO2021039023A1 (ja) | 2019-08-23 | 2021-03-04 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の製造方法 |
| CN112409191A (zh) | 2019-08-23 | 2021-02-26 | 持田制药株式会社 | 光学活性的氨基醇的制备方法 |
| JP6966667B2 (ja) * | 2019-08-27 | 2021-11-17 | 参天製薬株式会社 | ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 |
| JP7419728B2 (ja) | 2019-09-27 | 2024-01-23 | ブラザー工業株式会社 | 通信装置と通信装置のためのコンピュータプログラム |
| MY207759A (en) | 2019-10-04 | 2025-03-17 | Mochida Pharm Co Ltd | Pharmaceutical drug containing heterocyclidene acetamide derivative |
-
2022
- 2022-03-29 CA CA3215750A patent/CA3215750A1/en active Pending
- 2022-03-29 WO PCT/JP2022/015691 patent/WO2022210784A1/ja not_active Ceased
- 2022-03-29 JP JP2022546133A patent/JP7175431B1/ja active Active
- 2022-03-29 CN CN202280026310.3A patent/CN117120048A/zh active Pending
- 2022-03-29 EP EP22780995.1A patent/EP4316485A4/en active Pending
- 2022-03-29 AU AU2022250028A patent/AU2022250028A1/en active Pending
- 2022-03-29 US US18/553,141 patent/US12564553B2/en active Active
- 2022-03-29 MX MX2023011649A patent/MX2023011649A/es unknown
- 2022-03-29 BR BR112023019820A patent/BR112023019820A2/pt unknown
- 2022-03-29 KR KR1020237037161A patent/KR20230163502A/ko active Pending
- 2022-11-08 JP JP2022178888A patent/JP7273235B2/ja active Active
-
2023
- 2023-04-27 JP JP2023073689A patent/JP2023099107A/ja active Pending
-
2025
- 2025-01-03 US US19/009,331 patent/US12527740B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3215750A1 (en) | 2022-10-06 |
| US20240180827A1 (en) | 2024-06-06 |
| JP2023099107A (ja) | 2023-07-11 |
| US12527740B2 (en) | 2026-01-20 |
| JPWO2022210784A1 (https=) | 2022-10-06 |
| AU2022250028A1 (en) | 2023-11-16 |
| US20250134808A1 (en) | 2025-05-01 |
| JP7175431B1 (ja) | 2022-11-18 |
| KR20230163502A (ko) | 2023-11-30 |
| MX2023011649A (es) | 2023-10-11 |
| JP2023011898A (ja) | 2023-01-24 |
| EP4316485A4 (en) | 2025-03-26 |
| WO2022210784A1 (ja) | 2022-10-06 |
| EP4316485A1 (en) | 2024-02-07 |
| JP7273235B2 (ja) | 2023-05-12 |
| CN117120048A (zh) | 2023-11-24 |
| US12564553B2 (en) | 2026-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112023019820A2 (pt) | Suspensão contendo derivado de heterociclidenoacetamida | |
| BR112021017594A2 (pt) | Substrato gerador de aerossol compreendendo um filme gerador de aerossol | |
| BR112018000592A2 (pt) | composição de desbloqueio de nariz congestionado tendo atividade antiviral | |
| BR112018017323A2 (pt) | dobradiça com meio de abertura elástico para folhas de porta de mobília | |
| BR112022021939A2 (pt) | Limitador de profundidade de cânula com múltiplos diâmetros | |
| MX2019003611A (es) | Formulaciones novedosas. | |
| CL2009000624A1 (es) | Composicion farmaceutica oftalmica que comprende un vehiculo que incluye agua, un agente terapeutico que es una prostaglandina, un compuesto de amonio cuaternario polimerico y 0,01-04% p/v de un surfafactante que es aceite vegetal etoxilado y/o hidrogenado, libre de cloruro de benzxalconio; util para tratar glaucoma | |
| BRPI0819081A8 (pt) | Formulação oftálmica aquosa, processo para preparar a mesma, e, método para inibir, tratar ou prevenir doenças oculares e doença ou condição relacionada, em um paciente em necessidade de tal tratamento | |
| BR112018075579A2 (pt) | sistemas e métodos para corrigir e prevenir a oclusão em um cateter | |
| BR112016025261A2 (pt) | método para usar um aparelho para adquirir uma pluralidade de artigos irregulares, e, aparelho para adquirir uma pluralidade de artigos irregulares | |
| CL2020002838A1 (es) | Suspensión acuosa concentrada en cápsulas que contiene un protector de herbicidas y un agente plaguicida | |
| PH12022550474A1 (en) | Aqueous ophthalmic composition comprising diquafosol or salt thereof and polyvinylpyrrolidone | |
| TWD206889S (zh) | 護目鏡之部分 | |
| MX2017016660A (es) | Soluciones de esteroide neuroactivo y sus metodos de uso. | |
| FR3068042B1 (fr) | Nouveau melange tensioactif, nouvelle composition en comprenant et son utilisation dans les emulseurs pour combattre les incendies | |
| MX2021002935A (es) | Formulacion de anticuerpos contra csf-1r. | |
| BR112018071523A8 (pt) | Composições antimicrobianas espumantes | |
| BR112016007023A2 (pt) | oclusor para obstrução de uma passagem em um sistema circulatório | |
| SA522432474B1 (ar) | هلام بوليمر بعامل ربط تشـابكي ومـادة مالئة | |
| BR112021017612A2 (pt) | Película geradora de aerossol | |
| BR112018007175A2 (pt) | composição de pós-revestimento para fibras de reforço | |
| BR112021020694A2 (pt) | Composições farmacêuticas de bilastina estáveis e preservadas | |
| MX2018010161A (es) | Una manga desechable que tiene propiedad antimicrobiana para cubrir un brazo de un par de gafas. | |
| MX2025003326A (es) | Suspension esterilizada que contiene un derivado de heterociclideno acetamida | |
| BR0212245A (pt) | Composição emulsificante, agente de engraxamento para engraxar couro, uso da composição emulsificante, e, processo para engraxar couro e peles |